317 related articles for article (PubMed ID: 29499139)
1. CRISPR RNA-Dependent Binding and Cleavage of Endogenous RNAs by the Campylobacter jejuni Cas9.
Dugar G; Leenay RT; Eisenbart SK; Bischler T; Aul BU; Beisel CL; Sharma CM
Mol Cell; 2018 Mar; 69(5):893-905.e7. PubMed ID: 29499139
[TBL] [Abstract][Full Text] [Related]
2. Programmable RNA Cleavage and Recognition by a Natural CRISPR-Cas9 System from Neisseria meningitidis.
Rousseau BA; Hou Z; Gramelspacher MJ; Zhang Y
Mol Cell; 2018 Mar; 69(5):906-914.e4. PubMed ID: 29456189
[TBL] [Abstract][Full Text] [Related]
3. Identification of RNA Binding Partners of CRISPR-Cas Proteins in Prokaryotes Using RIP-Seq.
Sharma S; Sharma CM
Methods Mol Biol; 2022; 2404():111-133. PubMed ID: 34694606
[TBL] [Abstract][Full Text] [Related]
4. The tracrRNA and Cas9 families of type II CRISPR-Cas immunity systems.
Chylinski K; Le Rhun A; Charpentier E
RNA Biol; 2013 May; 10(5):726-37. PubMed ID: 23563642
[TBL] [Abstract][Full Text] [Related]
5. Crystal Structure of the Minimal Cas9 from Campylobacter jejuni Reveals the Molecular Diversity in the CRISPR-Cas9 Systems.
Yamada M; Watanabe Y; Gootenberg JS; Hirano H; Ran FA; Nakane T; Ishitani R; Zhang F; Nishimasu H; Nureki O
Mol Cell; 2017 Mar; 65(6):1109-1121.e3. PubMed ID: 28306506
[TBL] [Abstract][Full Text] [Related]
6. The CRISPR-cas system promotes antimicrobial resistance in Campylobacter jejuni.
Shabbir MA; Wu Q; Shabbir MZ; Sajid A; Ahmed S; Sattar A; Tang Y; Li J; Maan MK; Hao H; Yuan Z
Future Microbiol; 2018 Dec; 13():1757-1774. PubMed ID: 30526040
[TBL] [Abstract][Full Text] [Related]
7. Noncanonical crRNAs derived from host transcripts enable multiplexable RNA detection by Cas9.
Jiao C; Sharma S; Dugar G; Peeck NL; Bischler T; Wimmer F; Yu Y; Barquist L; Schoen C; Kurzai O; Sharma CM; Beisel CL
Science; 2021 May; 372(6545):941-948. PubMed ID: 33906967
[TBL] [Abstract][Full Text] [Related]
8. Cut site selection by the two nuclease domains of the Cas9 RNA-guided endonuclease.
Chen H; Choi J; Bailey S
J Biol Chem; 2014 May; 289(19):13284-94. PubMed ID: 24634220
[TBL] [Abstract][Full Text] [Related]
9. Long-Term Effects of In Vivo Genome Editing in the Mouse Retina Using Campylobacter jejuni Cas9 Expressed via Adeno-Associated Virus.
Jo DH; Koo T; Cho CS; Kim JH; Kim JS; Kim JH
Mol Ther; 2019 Jan; 27(1):130-136. PubMed ID: 30470629
[TBL] [Abstract][Full Text] [Related]
10. Single-Stranded DNA Cleavage by Divergent CRISPR-Cas9 Enzymes.
Ma E; Harrington LB; O'Connell MR; Zhou K; Doudna JA
Mol Cell; 2015 Nov; 60(3):398-407. PubMed ID: 26545076
[TBL] [Abstract][Full Text] [Related]
11. crRNA complementarity shifts endogenous CRISPR-Cas systems between transcriptional repression and DNA defense.
Ratner HK; Weiss DS
RNA Biol; 2021 Nov; 18(11):1560-1573. PubMed ID: 33733999
[TBL] [Abstract][Full Text] [Related]
12. Targeted dual base editing with Campylobacter jejuni Cas9 by single AAV-mediated delivery.
Kweon J; Jang AH; Kwon E; Kim U; Shin HR; See J; Jang G; Lee C; Koo T; Kim S; Kim Y
Exp Mol Med; 2023 Feb; 55(2):377-384. PubMed ID: 36720917
[TBL] [Abstract][Full Text] [Related]
13. Real-time observation of flexible domain movements in CRISPR-Cas9.
Osuka S; Isomura K; Kajimoto S; Komori T; Nishimasu H; Shima T; Nureki O; Uemura S
EMBO J; 2018 May; 37(10):. PubMed ID: 29650679
[TBL] [Abstract][Full Text] [Related]
14. Engineered Campylobacter jejuni Cas9 variant with enhanced activity and broader targeting range.
Nakagawa R; Ishiguro S; Okazaki S; Mori H; Tanaka M; Aburatani H; Yachie N; Nishimasu H; Nureki O
Commun Biol; 2022 Mar; 5(1):211. PubMed ID: 35260779
[TBL] [Abstract][Full Text] [Related]
15. Discovery and Functional Characterization of Diverse Class 2 CRISPR-Cas Systems.
Shmakov S; Abudayyeh OO; Makarova KS; Wolf YI; Gootenberg JS; Semenova E; Minakhin L; Joung J; Konermann S; Severinov K; Zhang F; Koonin EV
Mol Cell; 2015 Nov; 60(3):385-97. PubMed ID: 26593719
[TBL] [Abstract][Full Text] [Related]
16. Extensive CRISPR RNA modification reveals chemical compatibility and structure-activity relationships for Cas9 biochemical activity.
O'Reilly D; Kartje ZJ; Ageely EA; Malek-Adamian E; Habibian M; Schofield A; Barkau CL; Rohilla KJ; DeRossett LB; Weigle AT; Damha MJ; Gagnon KT
Nucleic Acids Res; 2019 Jan; 47(2):546-558. PubMed ID: 30517736
[TBL] [Abstract][Full Text] [Related]
17. Kinetic characterization of Cas9 enzymes.
Liu MS; Gong S; Yu HH; Taylor DW; Johnson KA
Methods Enzymol; 2019; 616():289-311. PubMed ID: 30691648
[TBL] [Abstract][Full Text] [Related]
18. Anti-CRISPR AcrIIC3 discriminates between Cas9 orthologs via targeting the variable surface of the HNH nuclease domain.
Kim Y; Lee SJ; Yoon HJ; Kim NK; Lee BJ; Suh JY
FEBS J; 2019 Dec; 286(23):4661-4674. PubMed ID: 31389128
[TBL] [Abstract][Full Text] [Related]
19. Guide-free Cas9 from pathogenic
Saha C; Mohanraju P; Stubbs A; Dugar G; Hoogstrate Y; Kremers GJ; van Cappellen WA; Horst-Kreft D; Laffeber C; Lebbink JHG; Bruens S; Gaskin D; Beerens D; Klunder M; Joosten R; Demmers JAA; van Gent D; Mouton JW; van der Spek PJ; van der Oost J; van Baarlen P; Louwen R
Sci Adv; 2020 Jun; 6(25):eaaz4849. PubMed ID: 32596446
[TBL] [Abstract][Full Text] [Related]
20. Structural basis for RNA-guided DNA cleavage by IscB-ωRNA and mechanistic comparison with Cas9.
Schuler G; Hu C; Ke A
Science; 2022 Jun; 376(6600):1476-1481. PubMed ID: 35617371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
